Gamboa Cintia Kieffer, Samir Ranoda, Wu Chengyu, Mu Huiling
Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Pharm Nanotechnol. 2018;6(2):124-132. doi: 10.2174/2211738506666180420165547.
Oral delivery of biopharmaceuticals is limited by the absorption barriers in the Gastrointestinal Tract (GIT) such as low permeability across the biological membranes and the enzymatic degradation by proteases. In this study, lipid-based drug delivery systems were proposed to overcome these obstacles.
The aim of this study was to evaluate the effect of particle preparation methods and excipients on the characteristics of Solid Lipid Microparticles (SLM) and Solid Lipid Nanoparticles (SLN).
Different triglycerides (TG) were used as the major excipients for the SLM and SLN. Insulin was used as the model protein; insulin-phospholipid (PL) was prepared to increase drug lipophilicity and compatibility with lipid excipients. Four methods were used for preparing lipid particles, i.e. a Hot Melting Dispersion (HMD) technique, a Solvent Evaporation (SE) method, a modified Solvent Evaporation (mSE) method and a Spray Drying technique. The lipid particles were evaluated in terms of size, size distribution, surface morphology and drug Entrapment Efficiency (EE).
The results suggested that SE method was the most suitable method for preparing insulin-PL loaded Solid Lipid Particles (SLP). No differences were observed when the SLP with a Long Chain Triglyceride (LCT) either a Medium Chain Triglyceride (MCT) in term of size. 70-90% of the lipidified insulin was incorporated in the lipid particles.
The preparation methods affected the size and morphology of SLP significantly, and the selection of lipid excipient should be done based on specific application requirements. Furthermore, the use of the lipidified protein was an efficient way to encapsulate protein in lipid carriers.
生物制药的口服给药受到胃肠道(GIT)吸收屏障的限制,如生物膜的低渗透性以及蛋白酶的酶解作用。在本研究中,提出了基于脂质的药物递送系统来克服这些障碍。
本研究的目的是评估颗粒制备方法和辅料对固体脂质微粒(SLM)和固体脂质纳米粒(SLN)特性的影响。
不同的甘油三酯(TG)用作SLM和SLN的主要辅料。胰岛素用作模型蛋白;制备胰岛素 - 磷脂(PL)以增加药物的亲脂性以及与脂质辅料的相容性。使用四种方法制备脂质颗粒,即热熔分散(HMD)技术、溶剂蒸发(SE)法、改良溶剂蒸发(mSE)法和喷雾干燥技术。从粒径、粒径分布、表面形态和药物包封率(EE)方面对脂质颗粒进行评估。
结果表明,SE法是制备载胰岛素 - PL固体脂质颗粒(SLP)最合适的方法。当SLP中使用长链甘油三酯(LCT)或中链甘油三酯(MCT)时,在粒径方面未观察到差异。70 - 90%的脂质化胰岛素被包封在脂质颗粒中。
制备方法对SLP的粒径和形态有显著影响,应根据具体应用要求选择脂质辅料。此外,使用脂质化蛋白是将蛋白包封在脂质载体中的有效方法。